Next, tumor-related factors (DCP, AFP, AFP-L3, tumor size, tumor number, vascular invasion, TNM stage, and therapeutic method) were compared between the NBNC-HCC and the B/C-HCC patients according to the status of the semiannual and nonsemiannual surveillance. This evidence concerns the gene AFP and hepatocellular carcinoma.